These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29568780)

  • 21. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.
    Teschke R; Uetrecht J
    Ann Transl Med; 2021 Apr; 9(8):730. PubMed ID: 33987428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM.
    Kobayashi T; Iwaki M; Nogami A; Yoneda M
    J Clin Transl Hepatol; 2023 Oct; 11(5):1239-1245. PubMed ID: 37577239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.
    Teschke R
    Front Pharmacol; 2019; 10():730. PubMed ID: 31396080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
    Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
    Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced Liver Injury in Pediatrics.
    Monge-Urrea F; Montijo-Barrios E
    J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):391-395. PubMed ID: 35727646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
    Teschke R; Eickhoff A; Schulze J; Danan G
    Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced liver injury: a comprehensive review.
    Hosack T; Damry D; Biswas S
    Therap Adv Gastroenterol; 2023; 16():17562848231163410. PubMed ID: 36968618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing.
    González-Muñoz M; Monserrat Villatoro J; Marín-Serrano E; Stewart S; Bardón Rivera B; Marín J; Martínez de Soto L; Seco Meseguer E; Ramírez E
    Clin Case Rep; 2020 Dec; 8(12):3105-3109. PubMed ID: 33363890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
    Teschke R; Méndez-Sánchez N; Eickhoff A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment.
    Taneja S; Kumar P; Rathi S; Duseja A; Singh V; Dhiman RK; Chawla YK
    Ann Hepatol; 2017; 16(5):818-821. PubMed ID: 28809737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature.
    Verma N; Kumar P; Mitra S; Taneja S; Dhooria S; Das A; Duseja A; Dhiman RK; Chawla Y
    Hepatol Commun; 2018 Feb; 2(2):142-147. PubMed ID: 29404521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RUCAM in Drug and Herb Induced Liver Injury: The Update.
    Danan G; Teschke R
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-Drug Combinations Can Enhance Toxicity as Shown by Monocyte-Derived Hepatocyte-like Cells From Patients With Idiosyncratic Drug-Induced Liver Injury.
    Benesic A; Jalal K; Gerbes AL
    Toxicol Sci; 2019 Oct; 171(2):296-302. PubMed ID: 31407002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of drug-induced liver injury in a tertiary hospital in southern India.
    Koshy A; Mahadevan P; Mukkada RJ; Francis JV; Chettupuzha AP; Augustine P
    Natl Med J India; 2022; 35(2):78-81. PubMed ID: 36461852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison.
    Lei X; Zhang J; Xu Q; Li J; Qian Y; Zhang J; Liu L; Zhong W; Wang Y; Han X; Tang J; Zeng M; Mao Y
    J Int Med Res; 2021 Aug; 49(8):3000605211039810. PubMed ID: 34433332
    [No Abstract]   [Full Text] [Related]  

  • 37. Highlights of the drug-induced liver injury literature for 2021.
    Woo SM; Alhaqqan DM; Gildea DT; Patel PA; Cundra LB; Lewis JH
    Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):767-785. PubMed ID: 35839342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
    Louissaint J; Kassab I; Yeboah-Korang A; Fontana RJ
    Dig Dis Sci; 2022 Aug; 67(8):4243-4249. PubMed ID: 34427818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM.
    Shi X; Zuo C; Yu L; Lao D; Li X; Xu Q; Lv Q
    Front Pharmacol; 2021; 12():761167. PubMed ID: 34795591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.